434 related articles for article (PubMed ID: 16971981)
1. Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.
Machackova J; Barta J; Dhalla NS
Can J Cardiol; 2006 Sep; 22(11):953-68. PubMed ID: 16971981
[TBL] [Abstract][Full Text] [Related]
2. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
[TBL] [Abstract][Full Text] [Related]
3. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
[TBL] [Abstract][Full Text] [Related]
4. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
Babick AP; Dhalla NS
Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
[TBL] [Abstract][Full Text] [Related]
5. Cardiac contractile proteins in hypertrophied and failing guinea pig heart.
Malhotra A; Siri FM; Aronson R
Cardiovasc Res; 1992 Feb; 26(2):153-61. PubMed ID: 1533346
[TBL] [Abstract][Full Text] [Related]
6. Myofibrillar abnormalities following cardiac muscle cell injury.
Ferrans VJ; Buja LM; Maron BJ
Recent Adv Stud Cardiac Struct Metab; 1975; 6():367-82. PubMed ID: 1105713
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of subcellular remodelling in post-infarct heart failure.
Dhalla NS; Kaura D; Liu X; Beamish RE
EXS; 1996; 76():463-77. PubMed ID: 8805812
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural studies of myocardial biopsies in 45 patients with obstructive or congestive cardiomyopathy.
Ferrans VJ; Massumi RA; Shugoll GI; Ali N; Roberts WC
Recent Adv Stud Cardiac Struct Metab; 1973; 2():231-72. PubMed ID: 4283352
[No Abstract] [Full Text] [Related]
9. Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.
Dhalla NS; Rangi S; Babick AP; Zieroth S; Elimban V
Heart Fail Rev; 2012 Sep; 17(4-5):671-81. PubMed ID: 21850540
[TBL] [Abstract][Full Text] [Related]
10. Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure.
Taylor MR; Bristow MR
Novartis Found Symp; 2006; 274():73-83; discussion 83-9, 152-5, 272-6. PubMed ID: 17019807
[TBL] [Abstract][Full Text] [Related]
11. Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency.
Pagani ED; Alousi AA; Grant AM; Older TM; Dziuban SW; Allen PD
Circ Res; 1988 Aug; 63(2):380-5. PubMed ID: 2969307
[TBL] [Abstract][Full Text] [Related]
12. Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine.
Okafor C; Liao R; Perreault-Micale C; Li X; Ito T; Stepanek A; Doye A; de Tombe P; Gwathmey JK
Mol Cell Biochem; 2003 Mar; 245(1-2):77-89. PubMed ID: 12708747
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural aspects of contractile proteins in cardiac hypertrophy and failure.
Ferrans VJ; Maron BJ; Jones M; Thiedemann KU
Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():129-40. PubMed ID: 145635
[TBL] [Abstract][Full Text] [Related]
14. Metabolic remodeling in hypertrophied and failing myocardium: a review.
Peterzan MA; Lygate CA; Neubauer S; Rider OJ
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H597-H616. PubMed ID: 28646030
[TBL] [Abstract][Full Text] [Related]
15. Cardiac myofibrillar contractile properties during the progression from hypertension to decompensated heart failure.
Hanft LM; Emter CA; McDonald KS
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H103-H113. PubMed ID: 28455288
[TBL] [Abstract][Full Text] [Related]
16. Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure.
Sarkar S; Chawla-Sarkar M; Young D; Nishiyama K; Rayborn ME; Hollyfield JG; Sen S
J Biol Chem; 2004 Dec; 279(50):52630-42. PubMed ID: 15385543
[TBL] [Abstract][Full Text] [Related]
17. Altered myofilament structure and function in dogs with Duchenne muscular dystrophy cardiomyopathy.
Ait Mou Y; Lacampagne A; Irving T; Scheuermann V; Blot S; Ghaleh B; de Tombe PP; Cazorla O
J Mol Cell Cardiol; 2018 Jan; 114():345-353. PubMed ID: 29275006
[TBL] [Abstract][Full Text] [Related]
18. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.
Murdoch CE; Zhang M; Cave AC; Shah AM
Cardiovasc Res; 2006 Jul; 71(2):208-15. PubMed ID: 16631149
[TBL] [Abstract][Full Text] [Related]
19. Molecular defects in cardiac myofibrillar proteins due to thyroid hormone imbalance and diabetes.
Machackova J; Barta J; Dhalla NS
Can J Physiol Pharmacol; 2005 Dec; 83(12):1071-91. PubMed ID: 16462907
[TBL] [Abstract][Full Text] [Related]
20. Increased Ca2+-sensitivity of myofibrillar tension in heart failure and its functional implication.
Brixius K; Savvidou-Zaroti P; Mehlhorn U; Bloch W; Kranias EG; Schwinger RH
Basic Res Cardiol; 2002; 97 Suppl 1():I111-7. PubMed ID: 12479244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
